Study: 27 Percent of CBD Products Would Fail Legal Weed’s Dosage Testing
Posted On June 15, 2020
- Researchers found that about 27 percent of products had variances in claims versus potency that wouldn’t pass the standard for products sold in state-legal marijuana industries.
- According to LeafReport, 10 percent is considered the maximum cannabinoid variance in the marijuana industry, and 27 of the 37 products tested (73 percent) fell within that margin of error.
- We thought we would see a lot of products that have a larger variance than 10 percent, which is the acceptable variance,” Gans explains.
Read full article: westword.com